Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fennec Pharmaceuticals Q3 EPS $(0.21) Misses $(0.10) Estimate, Sales $6.97M Miss $8.82M Estimate

Author: Benzinga Newsdesk | November 07, 2024 06:16am
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.10) by 110 percent. This is a 200 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $6.97 million which missed the analyst consensus estimate of $8.82 million by 20.93 percent. This is a 7.05 percent increase over sales of $6.51 million the same period last year.

Posted In: FENC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist